Compass Minerals Reports Fiscal 2022 Third-Quarter Results
Compass Minerals (NYSE: CMP) reported an 8% revenue increase to $215 million for Q3 2022, driven by a 36% rise in Plant Nutrition pricing. Despite growth, the company faced operating losses of $3.5 million due to rising production costs, particularly in the Salt segment. Total cash flow from operations decreased by $48.2 million year-over-year. The company narrowed its fiscal 2022 consolidated adjusted EBITDA guidance to $175-$195 million, reflecting ongoing margin compression. The Salt segment anticipates a 14% increase in average contract prices for the upcoming winter season.
- 8% revenue growth year-over-year to $215 million.
- 36% year-over-year increase in Plant Nutrition pricing.
- Successfully paid down debt from previous business sales.
- Operating loss of $3.5 million for Q3 2022.
- Adjusted EBITDA declined to $28.9 million from $33.3 million.
- Salt segment operating margin decreased to 8% from 13% year-over-year.
Fiscal 2022 Third-Quarter and Recent Highlights
-
Achieved revenue of
, an$215 million 8% year-over-year increase
-
Increased
Plant Nutrition pricing by36% year over year, and12% sequentially to per ton, reflecting continued strength in global fertilizer supply-demand conditions$827
-
Reduced Total Case Incident Rate1, or TCIR, by over half, to a rate of 0.95 for the nine months ended
June 30, 2022 , reflecting an approximate58% improvement year over year and the continuation of an excellent safety performance to date
- Amended credit facility to provide financial flexibility and bridge the timing gap between the fiscal 2022 inflationary dynamic that has led to Salt EBITDA margin compression to date and the anticipated fiscal 2023 post-bidding season Salt EBITDA margin recovery
- Announced the signing of non-binding memorandums of understanding to supply LG Energy Solution and Ford Motor Company with a battery-grade lithium product from the company’s lithium brine development project
-
Paid down debt with the combined net proceeds from the previously announced sale of the company's
South America chemicals business inApril 2022 and receipt of the maximum earnout associated with theJuly 2021 sale of itsSouth America specialty plant nutrition business
-
Bolstered board of directors with the appointment of
Richard P. Dealy andMelissa M. Miller , deepening the board's operational, financial, and human capital management expertise and experience
All amounts in this press release represent results from continuing operations, except for amounts pertaining to the condensed consolidated statements of cash flows which include results from
1 Rate of work-related injuries per 100 full time workers during a one-year period.
Results
(From continuing operations; in millions, except per share data) |
|
Three Months Ended
|
|
Nine Months Ended
|
||||
Revenue |
|
$ |
214.7 |
|
|
$ |
994.7 |
|
Operating (loss) earnings |
|
|
(3.5 |
) |
|
|
36.9 |
|
Adjusted EBITDA2 |
|
|
28.9 |
|
|
|
152.1 |
|
Net loss |
|
|
(10.7 |
) |
|
|
(31.8 |
) |
Net loss per diluted share |
|
|
(0.32 |
) |
|
|
(0.94 |
) |
Adjusted net (loss) earnings2 |
|
|
(5.2 |
) |
|
|
19.4 |
|
Adjusted net (loss) earnings2 per diluted share |
|
|
(0.16 |
) |
|
|
0.56 |
|
2 Non-GAAP financial measure. Reconciliations to the most directly comparable GAAP financial measure are provided in tables at the end of this press release.
“We achieved third-quarter revenue growth of
Fiscal 2022 third-quarter consolidated revenue grew
Salt Segment Summary
Salt segment fiscal 2022 third-quarter revenue totaled
Salt segment operating earnings in the fiscal 2022 third quarter declined
Bid Season
Approximately
Plant Nutrition Segment Summary
Cash Flow
Net cash provided from operating activities amounted to
Net cash used in investing activities was
Net cash used for financing activities was
The company ended the quarter with
Outlook
The company is narrowing its fiscal 2022 consolidated adjusted EBITDA estimate to a range of
FISCAL 2022 Guidance (for continuing operations): |
||||
|
|
2H FY22 |
|
FY22 |
Consolidated |
|
|
|
|
Adjusted EBITDA |
|
|
|
|
Salt Segment |
|
|
|
|
Volume |
|
|
|
12.3 million to 12.6 million tons |
Revenue |
|
|
|
|
EBITDA |
|
|
|
|
Plant Nutrition Segment |
|
|
|
|
Volume |
|
|
|
270,000 to 280,000 tons |
Revenue |
|
|
|
|
EBITDA |
|
|
|
|
Corporate |
|
|
|
|
Corporate and other expense1 |
|
|
|
|
Interest expense |
|
|
|
|
Depreciation, depletion and amortization |
|
|
|
|
Capital expenditures |
|
|
|
|
Effective tax rate2 |
|
|
|
~ |
1 Excludes depreciation, amortization and stock-based compensation.
2 Excludes tax expense from valuation allowance.
Conference Call
A corporate presentation with fiscal 2022 third-quarter performance results will also be available at investors.compassminerals.com.
About
Forward-Looking Statements and Other Disclaimers
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements about Salt profitability recovery; the company's lithium brine development project; earnings potential; ability to optimize mix and pass through inflationary costs; strategy; efforts to expand the company's minerals portfolio; bid season, including expected pricing and volumes;
The company has completed an initial assessment to define the lithium resource at Compass Minerals’ existing operations in accordance with applicable
Non-GAAP Measures
In addition to using
Management uses EBITDA, EBITDA adjusted for items which management believes are not indicative of the company’s ongoing operating performance (“Adjusted EBITDA”) and EBITDA margin to evaluate the operating performance of the company’s core business operations because its resource allocation, financing methods and cost of capital, and income tax positions are managed at a corporate level, apart from the activities of the operating segments, and the operating facilities are located in different taxing jurisdictions, which can cause considerable variation in net earnings. Management also uses adjusted operating earnings, adjusted operating margin, adjusted net earnings, and adjusted net earnings per diluted share, which eliminate the impact of certain items that management does not consider indicative of underlying operating performance. The presentation of these measures should not be construed as an inference that future results will be unaffected by unusual or non-recurring items. Management believes these non-GAAP financial measures provide management and investors with additional information that is helpful when evaluating underlying performance. EBITDA and Adjusted EBITDA exclude interest expense, income taxes and depreciation and amortization, each of which are an essential element of the company’s cost structure and cannot be eliminated. In addition, Adjusted EBITDA and Adjusted EBITDA margin exclude certain cash and non-cash items, including stock-based compensation. Consequently, any measure that excludes these elements has material limitations. The non-GAAP financial measures used by management should not be considered in isolation or as a substitute for net earnings, operating earnings, cash flows or other financial data prepared in accordance with GAAP or as a measure of overall profitability or liquidity. These measures are not necessarily comparable to similarly titled measures of other companies due to potential inconsistencies in the method of calculation. The calculation of non-GAAP financial measures as used by management is set forth in the following tables. All margin numbers are defined as the relevant measure divided by sales. The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the company’s results.
Reconciliation for Adjusted Net (Loss) Earnings (unaudited, in millions) |
||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
|||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
Net (loss) earnings from continuing operations |
$ |
(10.7 |
) |
|
$ |
(16.4 |
) |
|
$ |
(31.8 |
) |
|
$ |
40.2 |
Executive transition costs, net of tax(1) |
|
— |
|
|
|
— |
|
|
|
3.2 |
|
|
|
— |
Accrued loss and legal costs related to |
|
3.1 |
|
|
|
0.3 |
|
|
|
17.6 |
|
|
|
3.5 |
Deferred tax valuation allowance(3) |
|
2.4 |
|
|
|
— |
|
|
|
30.4 |
|
|
|
— |
Adjusted net (loss) earnings from continuing operations |
$ |
(5.2 |
) |
|
$ |
(16.1 |
) |
|
$ |
19.4 |
|
|
$ |
43.7 |
|
|
|
|
|
|
|
|
|||||||
Net (loss) earnings from continuing operations per diluted share |
$ |
(0.32 |
) |
|
$ |
(0.49 |
) |
|
$ |
(0.94 |
) |
|
$ |
1.15 |
Adjusted net (loss) earnings from continuing operations per diluted share |
$ |
(0.16 |
) |
|
$ |
(0.48 |
) |
|
$ |
0.56 |
|
|
$ |
1.25 |
Weighted-average common shares outstanding (in thousands): |
|
|
|
|
|
|
|
|||||||
Diluted |
|
34,154 |
|
|
|
34,078 |
|
|
|
34,110 |
|
|
|
34,022 |
(1) |
The company incurred severance and other costs related to executive transition of |
(2) |
The company recorded a contingent loss accrual and recognized costs, net of reimbursements, related to the ongoing |
(3) |
The company recognized a valuation allowance for certain deferred tax assets due to their uncertainty of being realized. |
Reconciliation for Adjusted Operating (Loss) Earnings (unaudited, in millions) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Operating (loss) earnings |
$ |
(3.5 |
) |
|
$ |
0.9 |
|
|
$ |
36.9 |
|
|
$ |
105.0 |
|
Executive transition costs(1) |
|
— |
|
|
|
— |
|
|
|
3.8 |
|
|
|
— |
|
Accrued loss and legal costs related to |
|
2.8 |
|
|
|
0.3 |
|
|
|
19.5 |
|
|
|
4.7 |
|
Adjusted operating (loss) earnings |
$ |
(0.7 |
) |
|
$ |
1.2 |
|
|
$ |
60.2 |
|
|
$ |
109.7 |
|
Sales |
|
214.7 |
|
|
|
199.4 |
|
|
|
994.7 |
|
|
|
934.1 |
|
Operating margin |
|
(1.6 |
) % |
|
|
0.5 |
% |
|
|
3.7 |
% |
|
|
11.2 |
% |
Adjusted operating margin |
|
(0.3 |
) % |
|
|
0.6 |
% |
|
|
6.1 |
% |
|
|
11.7 |
% |
(1) | The company incurred severance and other costs related to executive transition. |
(2) |
The company recorded a contingent loss accrual during the three and nine months ended |
Reconciliation for EBITDA and Adjusted EBITDA (unaudited, in millions) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Net (loss) earnings from continuing operations |
$ |
(10.7 |
) |
|
$ |
(16.4 |
) |
|
$ |
(31.8 |
) |
|
$ |
40.2 |
|
Interest expense |
|
13.4 |
|
|
|
15.0 |
|
|
|
41.2 |
|
|
|
46.2 |
|
Income tax (benefit) expense |
|
(1.1 |
) |
|
|
1.7 |
|
|
|
28.1 |
|
|
|
9.3 |
|
Depreciation, depletion and amortization |
|
27.0 |
|
|
|
30.0 |
|
|
|
83.2 |
|
|
|
90.0 |
|
EBITDA from continuing operations |
|
28.6 |
|
|
|
30.3 |
|
|
|
120.7 |
|
|
|
185.7 |
|
Adjustments to EBITDA from continuing operations: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation - non cash |
|
3.9 |
|
|
|
2.3 |
|
|
|
11.6 |
|
|
|
8.2 |
|
(Gain) loss on foreign exchange |
|
(6.1 |
) |
|
|
1.1 |
|
|
|
(3.5 |
) |
|
|
9.4 |
|
Executive transition costs(1) |
|
— |
|
|
|
— |
|
|
|
4.3 |
|
|
|
— |
|
Accrued loss and legal costs related to |
|
2.8 |
|
|
|
0.3 |
|
|
|
19.5 |
|
|
|
4.7 |
|
Other income, net |
|
(0.3 |
) |
|
|
(0.7 |
) |
|
|
(0.5 |
) |
|
|
(0.2 |
) |
Adjusted EBITDA from continuing operations |
|
28.9 |
|
|
|
33.3 |
|
|
|
152.1 |
|
|
|
207.8 |
|
Adjusted EBITDA from discontinued operations |
|
3.1 |
|
|
|
8.5 |
|
|
|
19.0 |
|
|
|
44.9 |
|
Adjusted EBITDA including discontinued operations |
$ |
32.0 |
|
|
$ |
41.8 |
|
|
$ |
171.1 |
|
|
$ |
252.7 |
|
(1) | The company incurred severance and other costs related to executive transition. |
(2) |
The company recorded a contingent loss accrual during the three and nine months ended |
Salt Segment Performance (unaudited, in millions, except for sales volumes and prices per short ton) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Sales |
$ |
156.2 |
|
|
$ |
142.6 |
|
|
$ |
821.4 |
|
|
$ |
740.1 |
|
Operating earnings |
$ |
12.4 |
|
|
$ |
19.2 |
|
|
$ |
101.1 |
|
|
$ |
155.3 |
|
Operating margin |
|
7.9 |
% |
|
|
13.5 |
% |
|
|
12.3 |
% |
|
|
21.0 |
% |
EBITDA(1) |
$ |
27.7 |
|
|
$ |
36.8 |
|
|
$ |
148.8 |
|
|
$ |
208.3 |
|
EBITDA(1) margin |
|
17.7 |
% |
|
|
25.8 |
% |
|
|
18.1 |
% |
|
|
28.1 |
% |
Sales volumes (in thousands of tons): |
|
|
|
|
|
|
|
||||||||
Highway deicing |
|
1,232 |
|
|
|
1,212 |
|
|
|
8,854 |
|
|
|
7,966 |
|
Consumer and industrial |
|
451 |
|
|
|
445 |
|
|
|
1,600 |
|
|
|
1,502 |
|
Total Salt |
|
1,683 |
|
|
|
1,657 |
|
|
|
10,454 |
|
|
|
9,468 |
|
Average prices (per ton): |
|
|
|
|
|
|
|
||||||||
Highway deicing |
$ |
63.73 |
|
|
$ |
59.42 |
|
|
$ |
61.25 |
|
|
$ |
61.98 |
|
Consumer and industrial |
$ |
172.41 |
|
|
$ |
158.78 |
|
|
$ |
174.47 |
|
|
$ |
164.08 |
|
Total Salt |
$ |
92.83 |
|
|
$ |
86.12 |
|
|
$ |
78.58 |
|
|
$ |
78.17 |
|
(1) | Non-GAAP financial measure. Reconciliations follow in these tables. |
Reconciliation for Salt Segment EBITDA (unaudited, in millions) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Reported GAAP segment operating earnings |
$ |
12.4 |
|
|
$ |
19.2 |
|
|
$ |
101.1 |
|
|
$ |
155.3 |
|
Depreciation, depletion and amortization |
|
15.3 |
|
|
|
17.6 |
|
|
|
47.7 |
|
|
|
53.0 |
|
Segment EBITDA |
$ |
27.7 |
|
|
$ |
36.8 |
|
|
$ |
148.8 |
|
|
$ |
208.3 |
|
Segment sales |
|
156.2 |
|
|
|
142.6 |
|
|
|
821.4 |
|
|
|
740.1 |
|
Segment EBITDA margin |
|
17.7 |
% |
|
|
25.8 |
% |
|
|
18.1 |
% |
|
|
28.1 |
% |
Plant Nutrition Segment Performance (unaudited, dollars in millions, except for prices per short ton) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Sales |
$ |
55.6 |
|
|
$ |
53.8 |
|
|
$ |
164.5 |
|
|
$ |
185.7 |
|
Operating earnings |
$ |
10.6 |
|
|
$ |
0.7 |
|
|
$ |
24.5 |
|
|
$ |
9.3 |
|
Operating margin |
|
19.1 |
% |
|
|
1.3 |
% |
|
|
14.9 |
% |
|
|
5.0 |
% |
EBITDA(1) |
$ |
19.4 |
|
|
$ |
9.8 |
|
|
$ |
50.9 |
|
|
$ |
36.2 |
|
EBITDA(1) margin |
|
34.9 |
% |
|
|
18.2 |
% |
|
|
30.9 |
% |
|
|
19.5 |
% |
Sales volumes (in thousands of tons) |
|
67 |
|
|
|
88 |
|
|
|
224 |
|
|
|
325 |
|
Average price (per ton) |
$ |
827 |
|
|
$ |
610 |
|
|
$ |
735 |
|
|
$ |
572 |
|
(1) Non-GAAP financial measure. Reconciliations follow in these tables. |
|||||||||||||||
Reconciliation for Plant Nutrition Segment EBITDA (unaudited, in millions) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Reported GAAP segment operating earnings |
$ |
10.6 |
|
|
$ |
0.7 |
|
|
$ |
24.5 |
|
|
$ |
9.3 |
|
Depreciation, depletion and amortization |
|
8.8 |
|
|
|
9.1 |
|
|
|
26.4 |
|
|
|
26.9 |
|
Segment EBITDA |
$ |
19.4 |
|
|
$ |
9.8 |
|
|
$ |
50.9 |
|
|
$ |
36.2 |
|
Segment sales |
|
55.6 |
|
|
|
53.8 |
|
|
|
164.5 |
|
|
|
185.7 |
|
Segment EBITDA margin |
|
34.9 |
% |
|
|
18.2 |
% |
|
|
30.9 |
% |
|
|
19.5 |
% |
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited, in millions, except share and per-share data) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Sales |
$ |
214.7 |
|
|
$ |
199.4 |
|
|
$ |
994.7 |
|
|
$ |
934.1 |
|
Shipping and handling cost |
|
58.7 |
|
|
|
51.6 |
|
|
|
314.5 |
|
|
|
250.4 |
|
Product cost |
|
122.1 |
|
|
|
117.6 |
|
|
|
521.8 |
|
|
|
486.6 |
|
Gross profit |
|
33.9 |
|
|
|
30.2 |
|
|
|
158.4 |
|
|
|
197.1 |
|
Selling, general and administrative expenses |
|
37.4 |
|
|
|
29.3 |
|
|
|
121.5 |
|
|
|
92.1 |
|
Operating (loss) earnings |
|
(3.5 |
) |
|
|
0.9 |
|
|
|
36.9 |
|
|
|
105.0 |
|
Other expense: |
|
|
|
|
|
|
|
||||||||
Interest expense |
|
13.4 |
|
|
|
15.0 |
|
|
|
41.2 |
|
|
|
46.2 |
|
(Gain) loss on foreign exchange |
|
(6.1 |
) |
|
|
1.1 |
|
|
|
(3.5 |
) |
|
|
9.4 |
|
Other expense (income), net |
|
1.0 |
|
|
|
(0.5 |
) |
|
|
2.9 |
|
|
|
(0.1 |
) |
(Loss) earnings from continuing operations before income taxes |
|
(11.8 |
) |
|
|
(14.7 |
) |
|
|
(3.7 |
) |
|
|
49.5 |
|
Income tax (benefit) expense from continuing operations |
|
(1.1 |
) |
|
|
1.7 |
|
|
|
28.1 |
|
|
|
9.3 |
|
Net (loss) earnings from continuing operations |
|
(10.7 |
) |
|
|
(16.4 |
) |
|
$ |
(31.8 |
) |
|
$ |
40.2 |
|
Net earnings (loss) from discontinued operations |
|
2.8 |
|
|
|
73.5 |
|
|
|
14.2 |
|
|
|
(169.4 |
) |
Net (loss) earnings |
$ |
(7.9 |
) |
|
$ |
57.1 |
|
|
$ |
(17.6 |
) |
|
$ |
(129.2 |
) |
|
|
|
|
|
|
|
|
||||||||
Basic net (loss) earnings from continuing operations per common share |
$ |
(0.32 |
) |
|
$ |
(0.49 |
) |
|
$ |
(0.94 |
) |
|
$ |
1.15 |
|
Basic net earnings (loss) from discontinued operations per common share |
|
0.08 |
|
|
|
2.13 |
|
|
|
0.42 |
|
|
|
(4.98 |
) |
Basic net (loss) earnings per common share |
$ |
(0.23 |
) |
|
$ |
1.64 |
|
|
$ |
(0.52 |
) |
|
$ |
(3.83 |
) |
|
|
|
|
|
|
|
|
||||||||
Diluted net (loss) earnings from continuing operations per common share |
$ |
(0.32 |
) |
|
$ |
(0.49 |
) |
|
$ |
(0.94 |
) |
|
$ |
1.15 |
|
Diluted net earnings (loss) from discontinued operations per common share |
|
0.08 |
|
|
|
2.12 |
|
|
|
0.42 |
|
|
|
(4.98 |
) |
Diluted net (loss) earnings per common share |
$ |
(0.23 |
) |
|
$ |
1.63 |
|
|
$ |
(0.52 |
) |
|
$ |
(3.83 |
) |
Weighted-average common shares outstanding (in thousands):(1) |
|
|
|
|
|
|
|
||||||||
Basic |
|
34,154 |
|
|
|
34,020 |
|
|
|
34,105 |
|
|
|
33,984 |
|
Diluted |
|
34,154 |
|
|
|
34,078 |
|
|
|
34,110 |
|
|
|
34,022 |
|
(1) |
Weighted participating securities include RSUs and PSUs that receive non-forfeitable dividends and consist of 372,000 and 423,000 weighted participating securities for the three and nine months ended |
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited, in millions) |
|||||
|
|
|
|
||
|
|
2022 |
|
|
2021 |
ASSETS |
|||||
Cash and cash equivalents |
$ |
47.2 |
|
$ |
18.1 |
Receivables, net |
|
108.6 |
|
|
132.8 |
Inventories |
|
268.9 |
|
|
321.7 |
Current assets held for sale |
|
— |
|
|
9.9 |
Other current assets |
|
54.6 |
|
|
48.9 |
Property, plant and equipment, net |
|
802.5 |
|
|
830.5 |
Intangible and other noncurrent assets |
|
295.2 |
|
|
269.0 |
Total assets |
$ |
1,577.0 |
|
$ |
1,630.9 |
|
|
|
|
||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||
Current portion of long-term debt |
$ |
— |
|
$ |
— |
Current liabilities held for sale |
|
— |
|
|
9.6 |
Other current liabilities |
|
189.4 |
|
|
185.8 |
Long-term debt, net of current portion |
|
885.9 |
|
|
935.4 |
Deferred income taxes and other noncurrent liabilities |
|
200.8 |
|
|
207.0 |
Total stockholders' equity |
|
300.9 |
|
|
293.1 |
Total liabilities and stockholders' equity |
$ |
1,577.0 |
|
$ |
1,630.9 |
|
|||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
(unaudited, in millions) |
|||||||
|
Nine Months Ended |
||||||
|
|
2022 |
|
|
|
2021 |
|
Net cash provided by operating activities(1) |
$ |
148.9 |
|
|
$ |
197.1 |
|
|
|
|
|
||||
Cash flows from investing activities: |
|
|
|
||||
Capital expenditures(2) |
|
(68.9 |
) |
|
|
(61.0 |
) |
Proceeds from sale of business |
|
61.2 |
|
|
|
56.7 |
|
Investment in equity method investee |
|
(46.3 |
) |
|
|
(4.5 |
) |
Other, net |
|
0.9 |
|
|
|
3.7 |
|
|
|
|
|
||||
Net cash used in investing activities |
|
(53.1 |
) |
|
|
(5.1 |
) |
|
|
|
|
||||
Cash flows from financing activities: |
|
|
|
||||
Proceeds from revolving credit facility borrowings |
|
346.3 |
|
|
|
345.8 |
|
Principal payments on revolving credit facility borrowings |
|
(341.7 |
) |
|
|
(411.0 |
) |
Proceeds from issuance of long-term debt |
|
50.8 |
|
|
|
120.3 |
|
Principal payments on long-term debt |
|
(106.6 |
) |
|
|
(155.6 |
) |
Dividends paid |
|
(15.7 |
) |
|
|
(73.6 |
) |
Deferred financing costs |
|
(0.4 |
) |
|
|
(0.1 |
) |
Proceeds from stock option exercised |
|
0.3 |
|
|
|
1.4 |
|
Shares withheld to satisfy employee tax obligations |
|
(1.9 |
) |
|
|
(1.3 |
) |
Other, net |
|
(0.9 |
) |
|
|
(1.3 |
) |
|
|
|
|
||||
Net cash used in financing activities |
|
(69.8 |
) |
|
|
(175.4 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
0.2 |
|
|
|
2.9 |
|
Net change in cash and cash equivalents |
|
26.2 |
|
|
|
19.5 |
|
Cash and cash equivalents, beginning of the year |
|
21.0 |
|
|
|
34.1 |
|
|
|
|
|
||||
Cash and cash equivalents, end of period |
|
47.2 |
|
|
|
53.6 |
|
Less: cash and cash equivalents included in current assets held for sale |
|
— |
|
|
|
(27.3 |
) |
Cash and cash equivalents of continuing operations, end of period |
$ |
47.2 |
|
|
$ |
26.3 |
|
(1) |
Includes cash flows provided by (used in) discontinued operations of |
(2) |
Includes capital expenditures of |
SEGMENT INFORMATION (unaudited, in millions) |
||||||||||||||
Three Months Ended |
|
Salt |
|
Plant Nutrition |
|
Corporate
|
|
Total |
||||||
Sales to external customers |
|
$ |
156.2 |
|
$ |
55.6 |
|
$ |
2.9 |
|
|
$ |
214.7 |
|
Intersegment sales |
|
|
— |
|
|
1.9 |
|
|
(1.9 |
) |
|
|
— |
|
Shipping and handling cost |
|
|
52.2 |
|
|
6.5 |
|
|
— |
|
|
|
58.7 |
|
Operating earnings (loss)(2) |
|
|
12.4 |
|
|
10.6 |
|
|
(26.5 |
) |
|
|
(3.5 |
) |
Depreciation, depletion and amortization |
|
|
15.3 |
|
|
8.8 |
|
|
2.9 |
|
|
|
27.0 |
|
Total assets (as of end of period) |
|
|
980.6 |
|
|
441.2 |
|
|
155.2 |
|
|
|
1,577.0 |
|
Three Months Ended |
|
Salt |
|
Plant Nutrition |
|
Corporate
|
|
Total |
||||||
Sales to external customers |
|
$ |
142.6 |
|
$ |
53.8 |
|
$ |
3.0 |
|
|
$ |
199.4 |
|
Intersegment sales |
|
|
— |
|
|
2.5 |
|
|
(2.5 |
) |
|
|
— |
|
Shipping and handling cost |
|
|
44.3 |
|
|
7.3 |
|
|
— |
|
|
|
51.6 |
|
Operating earnings (loss)(2) |
|
|
19.2 |
|
|
0.7 |
|
|
(19.0 |
) |
|
|
0.9 |
|
Depreciation, depletion and amortization |
|
|
17.6 |
|
|
9.1 |
|
|
3.3 |
|
|
|
30.0 |
|
Total assets (as of end of period) |
|
|
986.5 |
|
|
456.6 |
|
|
98.5 |
|
|
|
1,541.6 |
|
Nine Months Ended |
|
Salt |
|
Plant Nutrition |
|
Corporate
|
|
Total |
||||||
Sales to external customers |
|
$ |
821.4 |
|
$ |
164.5 |
|
$ |
8.8 |
|
|
$ |
994.7 |
|
Intersegment sales |
|
|
— |
|
|
5.0 |
|
|
(5.0 |
) |
|
|
— |
|
Shipping and handling cost |
|
|
294.0 |
|
|
20.5 |
|
|
— |
|
|
|
314.5 |
|
Operating earnings (loss)(2) |
|
|
101.1 |
|
|
24.5 |
|
|
(88.7 |
) |
|
|
36.9 |
|
Depreciation, depletion and amortization |
|
|
47.7 |
|
|
26.4 |
|
|
9.1 |
|
|
|
83.2 |
|
Nine Months Ended |
|
Salt |
|
Plant Nutrition |
|
Corporate
|
|
Total |
||||||
Sales to external customers |
|
$ |
740.1 |
|
$ |
185.7 |
|
$ |
8.3 |
|
|
$ |
934.1 |
|
Intersegment sales |
|
|
— |
|
|
5.4 |
|
|
(5.4 |
) |
|
|
— |
|
Shipping and handling cost |
|
|
223.6 |
|
|
26.8 |
|
|
— |
|
|
|
250.4 |
|
Operating earnings (loss)(2) |
|
|
155.3 |
|
|
9.3 |
|
|
(59.6 |
) |
|
|
105.0 |
|
Depreciation, depletion and amortization |
|
|
53.0 |
|
|
26.9 |
|
|
10.1 |
|
|
|
90.0 |
|
(1) |
Corporate and other includes corporate entities, records management operations, equity method investments and other incidental operations and eliminations. Operating earnings (loss) for corporate and other includes indirect corporate overhead including costs for general corporate governance and oversight, lithium-related expenditures, as well as costs for the human resources, information technology, legal and finance functions. |
(2) |
Corporate operating results include a contingent loss accrual and costs, net of reimbursements, related to the ongoing |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220804005749/en/
Investor Contact
Interim Senior Director of Investor Relations
+1.913.344.9496
InvestorRelations@compassminerals.com
Media Contact
Chief Public Affairs and Sustainability Officer
+1.913.344.9198
MediaRelations@compassminerals.com
Source:
FAQ
What were the Q3 2022 earnings results for CMP?
What is the outlook for CMP's Salt segment in fiscal 2022?
What is the consolidated adjusted EBITDA guidance for CMP in fiscal 2022?